Abstract
Pay-for-delay settlements involve payments by manufacturers of brand-name drugs to manufacturers of generic drugs in exchange for a delay in the marketing of generic drugs. This report discusses the legal and economic implications of pay-for-delay settlements.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
